Enliven Therapeutics, Inc. (ELVN) vs Xenon Pharmaceuticals Inc. (XENE)
Enliven Therapeutics, Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. Xenon Pharmaceuticals Inc. is the larger, with a market value of $3.7B against $3.3B — 1.1× the size. Across the 10 metrics below, Enliven Therapeutics, Inc. leads on 7 and Xenon Pharmaceuticals Inc. on 3.
Valuation
Profitability
| Metric | ELVN | XENE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 28.40% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (15.31%) | (43.62%) | (57.72%) |
| Return on assets | (14.98%) | (41.54%) | (49.22%) |
| Return on invested capital | 0.00% | (88.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack